FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MICHAEL MCDEVITT

Research Profile

Chemicals & Drugs

Disorders

Physiology

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Procedures

Karyotyping

Living Beings

Concepts & Ideas

Cohort Studies

Co-author Network

Publications

TOP 3
Judith E Karp; Mark Levis; Karen Mackey; A MICHAEL MCDEVITT; Megan Othus; Keith William Pratz; MICHELLE RUDEK-RENAUT; Margaret Mary Showel; B Douglas Smith; John J Wright; Hetty Carraway; Kathleen Shannon Dorcy; L Austin Doyle; D Michelle Drye; Elihu H Estey; Elizabeth Garrett-Mayer; Douglas E Gladstone; Steven D Gore; Jacqueline M Greer; John M Pagel
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
Jeffrey J Pu; Hetty Carraway; Rong Hu; A MICHAEL MCDEVITT; Galina L Mukhina; Robert A Brodsky
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Amer M Zeidan; Hetty Carraway; Douglas E Gladstone; Steven D Gore; Jacqueline M Greer; Mark Levis; A MICHAEL MCDEVITT; Keith William Pratz; Rebecca M Ricklis; Margaret Mary Showel; B Douglas Smith; Hyun D Yun; Judith E Karp
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MICHAEL MCDEVITT (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Judith E Karp; Mark Levis; Karen Mackey; A MICHAEL MCDEVITT; Megan Othus; Keith William Pratz; MICHELLE RUDEK-RENAUT; Margaret Mary Showel; B Douglas Smith; John J Wright; Hetty Carraway; Kathleen Shannon Dorcy; L Austin Doyle; D Michelle Drye; Elihu H Estey; Elizabeth Garrett-Mayer; Douglas E Gladstone; Steven D Gore; Jacqueline M Greer; John M Pagel
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
Haematologica 2012;97(11):1736-42.
2012: Jeffrey J Pu; Hetty Carraway; Rong Hu; A MICHAEL MCDEVITT; Galina L Mukhina; Robert A Brodsky
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Haematologica 2012;97(8):1225-33.
2012: Amer M Zeidan; Hetty Carraway; Douglas E Gladstone; Steven D Gore; Jacqueline M Greer; Mark Levis; A MICHAEL MCDEVITT; Keith William Pratz; Rebecca M Ricklis; Margaret Mary Showel; B Douglas Smith; Hyun D Yun; Judith E Karp
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.
British journal of haematology 2012;158(2):198-207.
2012: Andres Jerez; Seiji Kojima; Austin G Kulasekararaj; Alan List; Jacqueline Boultwood; Anna Jankowska; Hideki Makishima; A MICHAEL MCDEVITT; Kathy McGraw; Azim Mohamedali; Alison R Moliterno; Ghulam J Mufti; Hideki Muramatsu; Christine L O'Keefe; Andrea Pellagatti; Bartlomiej Przychodzen; Mikkael A Sekeres; Yuka Sugimoto; Ramon Tiu; Amit Verma; Valeria Visconte; Jaroslaw P Maciejewski
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
Blood 2012;119(25):6109-17.
2012: Andres Jerez; Denise A S Batista; Lukasz Gondek; Anna Jankowska; Hideki Makishima; A MICHAEL MCDEVITT; Azim Mohamedali; Ghulam J Mufti; Christine L O'Keefe; Bartlomiej Przychodzen; Mikkael A Sekeres; Ramon Tiu; Jaroslaw P Maciejewski
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(12):1343-9.
2012: A MICHAEL MCDEVITT
Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
Seminars in oncology 2012;39(1):109-22.
2012: Judith E Karp; A MICHAEL MCDEVITT; Carlo Derecho; Valerie Ironside; Scott H Kaufmann; John J Wright; Gail R Roboz; John Palma; Jacqueline M Greer; Steven D Gore; Mitch Raponi; Mark Levis; Tatiana I Vener; B Douglas Smith; Sami Malek; Steven Galkin; Ellen K Ritchie; Lawrence E Morris; Hetty Carraway; Eric J Feldman; Christopher D Gocke; Yixin Wang; Elizabeth Garret-Mayer
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.
Blood 2012;119(1):55-63.
2012: Chris Cheadle; JINSHUI FAN; Reda E Girgis; Dmitry N Grigoryev; Sangjucta Barkataki; Kathleen C Barnes; Alan E Berger; Meher Boorgula; Laura K Hummers; Roger Johns; Stephen C Mathai; A MICHAEL MCDEVITT; Yumiko Sugawara; Tonya N Watkins; Fredrick M Wigley; Ari L Zaiman; Paul M Hassoun
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients.
PloS one 2012;7(4):e34951.
2011: Anna Jankowska; Alan F List; Eric D Hsi; Yun Huang; Hideki Makishima; A MICHAEL MCDEVITT; Christine L O'Keefe; Courtney Prince; Anjana Rao; Mikkael A Sekeres; Yuka Sugimoto; Hadrian Szpurka; Ramon Tiu; Fabiola Traina; Valeria Visconte; Jaroslaw P Maciejewski
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Blood 2011;118(14):3932-41.
2011: BRADY STEIN; Amit Verma; Donna M Williams; Christine O'Keefe; Ophelia Rogers; Jerry L Spivak; Roxann G Ingersoll; Jarek P Maciejewski; A MICHAEL MCDEVITT; Alison R Moliterno
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Haematologica 2011;96(10):1462-9.
2011: Amy Elizabeth Dezern; Ephraim J Fuchs; Steven D Gore; Richard J Jones; Judith E Karp; Sharon Kim; Leo Luznik; A MICHAEL MCDEVITT; B Douglas Smith; Anthony Sung; Mark Levis
Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(9):1404-9.
2011: Jin Kyun Park; Gang Zheng; Allan C Gelber; Christopher D Gocke; A MICHAEL MCDEVITT; ALAN BAER
Large-vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(20):e601-3.
2011: Hideki Makishima; Anna Jankowska; A MICHAEL MCDEVITT; Christine L O'Keefe; Simon Dujardin; Heather Cazzolli; Bartlomiej Przychodzen; Courtney Prince; John Nicoll; Harish Siddaiah; Mohammed Shaik; Hadrian Szpurka; Eric D Hsi; Anjali Advani; Ronald Paquette; Jaroslaw P Maciejewski
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
Blood 2011;117(21):e198-206.
2011: F. JAVIER BOLANOS MEADE; B Douglas Smith; Steven D Gore; A MICHAEL MCDEVITT; Leo Luznik; Ephraim J Fuchs; Richard J Jones
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(5):754-8.
2011: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Paul Elson; Jungwon Huh; Azim Mohamedali; Austin Kulasekararaj; Anjali Advani; Ronald Paquette; Alan F List; Mikkael A Sekeres; A MICHAEL MCDEVITT; Ghulam J Mufti; Jaroslaw P Maciejewski
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood 2011;117(17):4552-60.
2011: Youl-Nam Lee; Stephanie Brandal; Pierre Noel; Erik Wentzel; Joshua T Mendell; A MICHAEL MCDEVITT; Reuben Kapur; Melody Carter; Dean D Metcalfe; Clifford M Takemoto
KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.
Blood 2011;117(13):3629-40.
2011: Judith E Karp; B Douglas Smith; Linda M. Resar; Jacqueline M Greer; Amanda Blackford; Ming Zhao; Dwella Moton-Nelson; Katrina Alino; Mark Levis; Steven D Gore; Biju Joseph; Hetty Carraway; A MICHAEL MCDEVITT; Lorena Bagain; Karen Mackey; Janet Briel; L Austin Doyle; John J Wright; MICHELLE RUDEK-RENAUT
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.
Blood 2011;117(12):3302-10.
2010: Hideki Makishima; Anna Jankowska; Ramon Tiu; Hadrian Szpurka; Y Sugimoto; Z Hu; Yogen Saunthararajah; K Guinta; M A Keddache; P Putnam; Mikkael A Sekeres; Alison R Moliterno; Alan F List; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.
Leukemia 2010;24(10):1799-804.
2010: Elizabeth A Griffiths; Steven D Gore; Craig M Hooker; Helai P Mohammad; A MICHAEL MCDEVITT; B Douglas Smith; Judith E Karp; James G Herman; Hetty Carraway
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia.
Epigenetics : official journal of the DNA Methylation Society 2010;5(7):590-600.
2010: Elizabeth A Griffiths; Steven D Gore; Craig M Hooker; A MICHAEL MCDEVITT; Judith E Karp; B Douglas Smith; Helai P Mohammad; Ying Ye; James G Herman; Hetty Carraway
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Leukemia & lymphoma 2010;51(9):1711-9.
2010: Keith William Pratz; E Cho; Mark Levis; Judith E Karp; Steven D Gore; A MICHAEL MCDEVITT; A Stine; Ming Zhao; Sharyn D Baker; Michael A Carducci; John J Wright; MICHELLE RUDEK-RENAUT; B Douglas Smith
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias.
Leukemia 2010;24(8):1437-44.
2010: Judith E Karp; Amanda Blackford; B Douglas Smith; Katrina Alino; Amy Hatfield Seung; F. JAVIER BOLANOS MEADE; Jacqueline M Greer; Hetty Carraway; Steven D Gore; Richard J Jones; Mark Levis; A MICHAEL MCDEVITT; L Austin Doyle; John J Wright
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
Leukemia research 2010;34(7):877-82.
2010: A MICHAEL MCDEVITT
The Erg-onomics of myeloproliferation in Down syndrome.
Blood 2010;115(19):3859-60.
2010: Clifford M Takemoto; Stephanie Brandal; anil jegga; Youl-Nam Lee; Amir Shahlaee; Ye Ying; Rodney Dekoter; A MICHAEL MCDEVITT
PU.1 positively regulates GATA-1 expression in mast cells.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(8):4349-61.
2010: Christine L O'Keefe; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.
Blood 2010;115(14):2731-9.
2010: Jungwon Huh; Ramon V Tiu; Lukasz Gondek; Christine L O'Keefe; Monika Jasek; Hideki Makishima; Anna Jankowska; Ying Jiang; Amit Verma; Karl S Theil; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Genes, chromosomes & cancer 2010;49(4):390-9.
2010: Evan J Lipson; Carol Ann Huff; Danniele G Holanda; A MICHAEL MCDEVITT; Derek M Fine
Lenalidomide-induced acute interstitial nephritis.
The oncologist 2010;15(9):961-4.
2010: M Jasek; Lukasz Gondek; N Bejanyan; R Tiu; J Huh; K S Theil; C O'Keefe; A MICHAEL MCDEVITT; J P Maciejewski
TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p.
Leukemia 2010;24(1):216-9.
2009: Hideki Makishima; Heather Cazzolli; Hadrian Szpurka; Andrew Dunbar; Ramon Tiu; Jungwon Huh; Hideki Muramatsu; Christine O'Keefe; Eric Hsi; Ronald L Paquette; Seiji Kojima; Alan F List; Mikkael A Sekeres; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6109-16.
2009: Brian Garibaldi; Rupal Malani; Hsin-Chieh Yeh; Evan Lipson; Deborah Michell; Mosi Bennett; Alison R Moliterno; A MICHAEL MCDEVITT; Thomas S Kickler
Estimating platelet production in patients with HIV-related thrombocytopenia using the immature platelet fraction.
American journal of hematology 2009;84(12):852-4.
2009: Ying Ye; A MICHAEL MCDEVITT; Mingzhou Guo; Wei Zhang; Oliver Galm; Steven D Gore; Judith E Karp; Jaroslaw P Maciejewski; Jeanne Kowalski; Hua-Ling Tsai; Lukasz Gondek; Hsing-Chen Tsai; Xiaofei Wang; Craig M Hooker; B Douglas Smith; Hetty Carraway; James G Herman
Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Cancer research 2009;69(21):8482-90.
2009: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Jungwon Huh; Mikkael A Sekeres; Paul Elson; A MICHAEL MCDEVITT; Xiao Fei Wang; Mark Levis; Judith E Karp; Anjali Advani; Jaroslaw P Maciejewski
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5219-26.
2009: Toyoko Hiroi; Clayton B Deming; Haige Zhao; Baranda S Hansen; Elisabeth K Arkenbout; Thomas J Myers; A MICHAEL MCDEVITT; Jeffrey J Rade
Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1587-93.
2009: Anna Jankowska; Hadrian Szpurka; Ramon V Tiu; Hideki Makishima; Manuel Afable; Jungwon Huh; Christine L O'Keefe; Rebecca Ganetzky; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
Blood 2009;113(25):6403-10.
2008: Andrew J Dunbar; Lukasz Gondek; Christine L O'Keefe; Hideki Makishima; Manjot S Rataul; Hadrian Szpurka; Mikkael A Sekeres; Xiao Fei Wang; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
Cancer research 2008;68(24):10349-57.
2008: JASON FARRAR; Michelle Nater; Emi H Caywood; A MICHAEL MCDEVITT; Jeanne Kowalski; Clifford M Takemoto; C Conover Talbot; Paul Meltzer; Diane Esposito; Alan H Beggs; Hal E Schneider; Agnieszka Grabowska; Sarah E Ball; Edyta Niewiadomska; Colin A Sieff; Adrianna Vlachos; Eva Atsidaftos; Steven R Ellis; Jeffrey Lipton; Hanna T Gazda; Robert J Arceci
Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.
Blood 2008;112(5):1582-92.
2008: Clifford M Takemoto; Youl-Nam Lee; anil jegga; Daniella Zablocki; Stephanie Brandal; Amir Shahlaee; Suming Huang; Ying Ye; Sivakumar Gowrisankar; Jimmy Huynh; A MICHAEL MCDEVITT
Mast cell transcriptional networks.
Blood cells, molecules & diseases 2008;41(1):82-90.
2008: Jonathan K Alder; Robert W Georgantas; Richard L Hildreth; Ian M Kaplan; Sebastien Morisot; Xiaobing Yu; A MICHAEL MCDEVITT; Curt I Civin
Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(8):5645-52.
2007: Judith E Karp; Rebecca M Ricklis; Kumudha Balakrishnan; Janet Briel; Jacqueline Greer; Steven D Gore; B Douglas Smith; A MICHAEL MCDEVITT; Hetty Carraway; Mark Levis; Varsha Gandhi
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
Blood 2007;110(6):1762-9.
2007: K Eric Paulson; Kimberly M Rieger-Christ; A MICHAEL MCDEVITT; Charlotte Kuperwasser; Jiyoung Kim; Vincent E Unanue; Xiaowei Zhang; Maowen Hu; Robin Ruthazer; Stephen P Berasi; Chun-Yin Huang; Dilip Giri; Seth Kaufman; John M Dugan; Joanne Blum; George Netto; David E Wazer; Ian C Summerhayes; Amy Yee
Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
Cancer research 2007;67(13):6136-45.
2007: A MICHAEL MCDEVITT; M Condon; J Stamberg; Judith E Karp; Melissa A McDiarmid
Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
Mutation research 2007;629(1):24-31.
2007: Lukasz Gondek; Andrew J Dunbar; Hadrian Szpurka; A MICHAEL MCDEVITT; Jaroslaw P Maciejewski
SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
PloS one 2007;2(11):e1225.
2006: Xiaowei Zhang; Jiyoung Kim; Robin Ruthazer; A MICHAEL MCDEVITT; David E Wazer; K Eric Paulson; Amy Yee
The HBP1 transcriptional repressor participates in RAS-induced premature senescence.
Molecular and cellular biology 2006;26(22):8252-66.
2006: A MICHAEL MCDEVITT; Jianlin Xie; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip E Thuma; Victor Roland Gordeuk; Christine N Metz; Robert Mitchell; JEFFREY KEEFER; John David; Lin Leng; Richard Bucala
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
The Journal of experimental medicine 2006;203(5):1185-96.
2005: Rebecca C Osthus; Baktiar O Karim; Julia E Prescott; B Douglas Smith; A MICHAEL MCDEVITT; David L Huso; Chi Dang
The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.
Cancer research 2005;65(13):5620-7.
2004: Kamaleldin E Elagib; Mang Xiao; Isa M Hussaini; Lorrie L Delehanty; Lisa A Palmer; Frederick K Racke; Michael J Birrer; Ganapath Shanmugasundaram; A MICHAEL MCDEVITT; Adam N Goldfarb
Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.
Molecular and cellular biology 2004;24(17):7779-94.
2004: Amy Yee; Eric K Paulson; A MICHAEL MCDEVITT; Kimberly M Rieger-Christ; Ian C Summerhayes; Stephen P Berasi; Jiyoung Kim; Chun-Yin Huang; Xiaowei Zhang
The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression.
Gene 2004;336(1):1-13.
2004: A MICHAEL MCDEVITT; Jianlin Xie; Victor Roland Gordeuk; Richard Bucala
The anemia of malaria infection: role of inflammatory cytokines.
Current hematology reports 2004;3(2):97-106.
2003: Marianne E Greene; Gina Mundschau; Joshua Wechsler; A MICHAEL MCDEVITT; Alan S Gamis; Judith E Karp; Sandeep Gurbuxani; Robert J Arceci; John D Crispino
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Blood cells, molecules & diseases 2003;31(3):351-6.
2002: Joshua Wechsler; Marianne Greene; A MICHAEL MCDEVITT; John Anastasi; Judith E Karp; Michelle M Le Beau; John D Crispino
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Nature genetics 2002;32(1):148-52.
1999: P Vyas; A MICHAEL MCDEVITT; Alan B Cantor; Samuel G Katz; Yuko Fujiwara; Stuart H Orkin
Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene.
Development (Cambridge, England) 1999;126(12):2799-811.
1998: Stuart H Orkin; Ramesh A Shivdasani; Y Fujiwara; A MICHAEL MCDEVITT
Transcription factor GATA-1 in megakaryocyte development.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():79-83.
1997: A MICHAEL MCDEVITT; Y Fujiwara; Ramesh A Shivdasani; Stuart H Orkin
An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7976-81.
1997: Ramesh A Shivdasani; Y Fujiwara; A MICHAEL MCDEVITT; Stuart H Orkin
A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.
The EMBO journal 1997;16(13):3965-73.
1997: A MICHAEL MCDEVITT; Ramesh A Shivdasani; Y Fujiwara; Haifeng Yang; Stuart H Orkin
A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(13):6781-5.
1993: E John; Mathew L Thakur; J DeFulvio; A MICHAEL MCDEVITT; Ivan Damjanov
Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(2):260-7.
1992: Mathew L Thakur; J DeFulvio; J Tong; E John; A MICHAEL MCDEVITT; Ivan Damjanov
Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. A preliminary report.
Journal of immunological methods 1992;152(2):209-16.
1988: A MICHAEL MCDEVITT; G M Gilmartin; W H Reeves; Joseph R Nevins
Multiple factors are required for poly(A) addition to a mRNA 3' end.
Genes & development 1988;2(5):588-97.
1988: G M Gilmartin; A MICHAEL MCDEVITT; Joseph R Nevins
Multiple factors are required for specific RNA cleavage at a poly(A) addition site.
Genes & development 1988;2(5):578-87.
1987: G Galli; J W Guise; A MICHAEL MCDEVITT; P W Tucker; Joseph R Nevins
Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted mu-chain expression during B-cell development.
Genes & development 1987;1(5):471-81.
1986: A MICHAEL MCDEVITT; R P Hart; W W Wong; J R Nevins
Sequences capable of restoring poly(A) site function define two distinct downstream elements.
The EMBO journal 1986;5(11):2907-13.
1985: R P Hart; A MICHAEL MCDEVITT; J R Nevins
Poly(A) site cleavage in a HeLa nuclear extract is dependent on downstream sequences.
Cell 1985;43(3 Pt 2):677-83.
1985: R P Hart; A MICHAEL MCDEVITT; H Ali; J R Nevins
Definition of essential sequences and functional equivalence of elements downstream of the adenovirus E2A and the early simian virus 40 polyadenylation sites.
Molecular and cellular biology 1985;5(11):2975-83.
1984: A MICHAEL MCDEVITT; Michael J Imperiale; H Ali; J R Nevins
Requirement of a downstream sequence for generation of a poly(A) addition site.
Cell 1984;37(3):993-9.
1984: AG Goodridge; R A Jenik; A MICHAEL MCDEVITT; Sidney Morris; L K Winberry
Malic enzyme and fatty acid synthase in the uropygial gland and liver of embryonic and neonatal ducklings. Tissue-specific regulation of gene expression.
Archives of biochemistry and biophysics 1984;230(1):82-92.
1982: Sidney Morris; J H Nilson; R A Jenik; L K Winberry; A MICHAEL MCDEVITT; AG Goodridge
Molecular cloning of gene sequences for avian fatty acid synthase and evidence for nutritional regulation of fatty acid synthase mRNA concentration.
The Journal of biological chemistry 1982;257(6):3225-9.